Nathan D Donahue
Overview
Explore the profile of Nathan D Donahue including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
296
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Sheth V, Liu K, Panja P, Frickenstein A, He Y, et al.
Adv Mater
. 2024 Apr;
36(28):e2403986.
PMID: 38663008
Cancer nanomedicines predominately rely on transport processes controlled by tumor-associated endothelial cells to deliver therapeutic and diagnostic payloads into solid tumors. While the dominant role of this class of endothelial...
2.
Sheth V, Chen X, Mettenbrink E, Yang W, Jones M, MSaad O, et al.
ACS Nano
. 2023 Apr;
17(9):8376-8392.
PMID: 37071747
Super-resolution microscopy can transform our understanding of nanoparticle-cell interactions. Here, we established a super-resolution imaging technology to visualize nanoparticle distributions inside mammalian cells. The cells were exposed to metallic nanoparticles...
3.
Yang W, Frickenstein A, Sheth V, Holden A, Mettenbrink E, Wang L, et al.
Nano Lett
. 2022 Sep;
22(17):7119-7128.
PMID: 36048773
We used heparosan (HEP) polysaccharides for controlling nanoparticle delivery to innate immune cells. Our results show that HEP-coated nanoparticles were endocytosed in a time-dependent manner by innate immune cells via...
4.
Donahue N, Sheth V, Frickenstein A, Holden A, Kanapilly S, Stephan C, et al.
Nano Lett
. 2022 May;
22(10):4192-4199.
PMID: 35510841
We report on the absolute quantification of nanoparticle interactions with individual human B cells using quadrupole-based inductively coupled plasma mass spectrometry (ICP-MS). This method enables the quantification of nanoparticle-cell interactions...
5.
Yang W, Wang L, Fang M, Sheth V, Zhang Y, Holden A, et al.
Nano Lett
. 2022 Feb;
22(5):2103-2111.
PMID: 35166110
Nanoparticle modification with poly(ethylene glycol) (PEG) is a widely used surface engineering strategy in nanomedicine. However, since the artificial PEG polymer may adversely impact nanomedicine safety and efficacy, alternative surface...
6.
Donahue N, Kanapilly S, Stephan C, Marlin M, Francek E, Haddad M, et al.
Nano Lett
. 2021 Dec;
22(1):294-301.
PMID: 34962815
To control a nanoparticle's chemical composition and thus function, researchers require readily accessible and economical characterization methods that provide quantitative analysis of individual nanoparticles with high throughput. Here, we established...
7.
Kiyotake E, Thomas E, Homburg H, Milton C, Smitherman A, Donahue N, et al.
J Biomed Mater Res A
. 2021 Aug;
110(2):365-382.
PMID: 34390325
There is growing evidence indicating the need to combine the rehabilitation and regenerative medicine fields to maximize functional recovery after spinal cord injury (SCI), but there are limited methods to...
8.
Donahue N, Francek E, Kiyotake E, Thomas E, Yang W, Wang L, et al.
Anal Bioanal Chem
. 2020 Jul;
412(22):5205-5216.
PMID: 32627086
Biological interactions, toxicity, and environmental fate of engineered nanoparticles are affected by colloidal stability and aggregation. To assess nanoparticle aggregation, analytical methods are needed that allow quantification of individual nanoparticle...
9.
Donahue N, Acar H, Wilhelm S
Adv Drug Deliv Rev
. 2019 Apr;
143:68-96.
PMID: 31022434
Nanoparticle-based therapeutics and diagnostics are commonly referred to as nanomedicine and may significantly impact the future of healthcare. However, the clinical translation of these technologies is challenging. One of these...